PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction

J Cancer. 2023 May 15;14(8):1335. doi: 10.7150/jca.85747. eCollection 2023.

Authors

Ming Li¹, Weiwei Zhang², Shenjun Zhang³, Changhui Wang¹, Yinping Lin^{1

3}

Affiliations

¹ Department of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University, Shanghai 200072, China.
² Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
³ Institute of Biochemistry and Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

Abstract

[This retracts the article DOI: 10.7150/jca.18848.].

© Ivyspring International Publisher.

Publication types

Retraction of Publication